Open Access Case Report Article ID: AHR-3-113

    Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports

    Meng-Lan Wang, Dong-Mei Zhang and En-Qiang Chen*

    Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.

    Keywords: Entecavir; Chronic hepatitis B; Constipation; Adverse event

    Published on: May 29, 2017 Pages: 27-28

    Full Text PDF Full Text HTML DOI: 10.17352/ahr.000013
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AHR